{"transactions":[{"id":734199,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-18T00:30:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."}],"balance_after":1980,"derivative":{"underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001727275-26-000004","document":"form4-06172026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000172727526000004/form4-06172026_080609.xml","form_type":"4"}},{"id":734198,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:30:18.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":3772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":3772,"derivative":{"exercise_price":101,"expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":3772},"source":{"system":"sec-edgar","filing":"0001727275-26-000004","document":"form4-06172026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000172727526000004/form4-06172026_080609.xml","form_type":"4"}},{"id":741324,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:38:51.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests over a 12 month period: 1/12th on November 1, 2025, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":12.05,"expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001727275-26-000002","document":"form4-06112026_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000172727526000002/form4-06112026_080646.xml","form_type":"4"}},{"id":741323,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:38:51.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests over a 12 month period: 1/12th on November 3, 2024, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.54,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001727275-26-000002","document":"form4-06112026_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000172727526000002/form4-06112026_080646.xml","form_type":"4"}},{"id":741322,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:38:51.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a 36 month period: 1/36th on May 18, 2024, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.5,"expiration_date":"2034-04-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001727275-26-000002","document":"form4-06112026_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000172727526000002/form4-06112026_080646.xml","form_type":"4"}},{"id":1026617,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-02T22:29:40.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2025, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":12.05,"expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001727275-25-000003","document":"form4-10022025_101036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000172727525000003/form4-10022025_101036.xml","form_type":"4"}},{"id":1082742,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:37:18.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017025098041/ownership.xml","form_type":"4"}},{"id":1111766,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:18:54.000Z","date":"2025-06-11","kind":"sale","planned":false,"acquired":false,"shares":3203,"price":48.4204,"value":155090.5412,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001415889-25-017188","document":"form4-06132025_080649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925017188/form4-06132025_080649.xml","form_type":"4"}},{"id":1127747,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-02T23:35:26.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."}],"balance_after":3977,"derivative":{"underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0001415889-25-015302","document":"form4-06022025_110622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015302/form4-06022025_110622.xml","form_type":"4"}},{"id":1127746,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T23:35:26.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."}],"balance_after":6268,"derivative":{"exercise_price":44,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":6268},"source":{"system":"sec-edgar","filing":"0001415889-25-015302","document":"form4-06022025_110622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015302/form4-06022025_110622.xml","form_type":"4"}},{"id":1127745,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T23:35:26.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided  that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided  that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-25-015302","document":"form4-06022025_110622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015302/form4-06022025_110622.xml","form_type":"4"}},{"id":1127744,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T23:35:26.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":5703,"source":{"system":"sec-edgar","filing":"0001415889-25-015302","document":"form4-06022025_110622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015302/form4-06022025_110622.xml","form_type":"4"}},{"id":1340313,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:35:04.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134153/ownership.xml","form_type":"4"}},{"id":1390673,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T20:08:45.000Z","date":"2024-10-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12-month period: 1/12th on November 3, 2024, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":11.54,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-024753","document":"form4-10042024_081042.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000141588924024753/form4-10042024_081042.xml","form_type":"4"}},{"id":1425182,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:06:55.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024099837/ownership.xml","form_type":"4"}},{"id":1486937,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-07T22:19:10.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":5703,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-24-016063","document":"form4-06072024_100607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016063/form4-06072024_100607.xml","form_type":"4"}},{"id":1486936,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T22:19:10.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":8779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting."}],"balance_after":8779,"derivative":{"exercise_price":26.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8779},"source":{"system":"sec-edgar","filing":"0001415889-24-016063","document":"form4-06072024_100607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016063/form4-06072024_100607.xml","form_type":"4"}},{"id":1537462,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-22T20:35:50.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 36 month period: 1/36th on May 18, 2024, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":17000,"derivative":{"exercise_price":11.5,"expiration_date":"2034-04-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001415889-24-011319","document":"form4-04222024_080443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348911/000141588924011319/form4-04222024_080443.xml","form_type":"4"}},{"id":1751195,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T00:55:22.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service."}],"balance_after":5450,"derivative":{"exercise_price":1.17,"expiration_date":"2033-10-30","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0000899243-23-020117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924323020117/doc4.xml","form_type":"4"}},{"id":1855971,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-14T21:47:19.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting."}],"balance_after":17000,"derivative":{"exercise_price":28.97,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-23-037129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123037129/doc4.xml","form_type":"4"}},{"id":2242493,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T22:03:57.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":12750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2023 annual stockholder meeting."}],"balance_after":12750,"derivative":{"exercise_price":23.51,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":12750},"source":{"system":"sec-edgar","filing":"0001209191-22-034641","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122034641/doc4.xml","form_type":"4"}},{"id":2594987,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-20T21:17:04.000Z","date":"2021-08-19","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant."}],"balance_after":34000,"derivative":{"exercise_price":14.19,"expiration_date":"2031-08-18","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-21-052805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121052805/doc4.xml","form_type":"4"}},{"id":2972699,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:20:48.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":39022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":70.4,"underlying":"Common Stock","underlying_shares":39022},"source":{"system":"sec-edgar","filing":"0000899243-20-031757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031757/doc4.xml","form_type":"4"}},{"id":2972698,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:20:48.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":69500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":40.99,"underlying":"Common Stock","underlying_shares":69500},"source":{"system":"sec-edgar","filing":"0000899243-20-031757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031757/doc4.xml","form_type":"4"}},{"id":2972697,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-19T20:20:48.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":42199,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031757/doc4.xml","form_type":"4"}},{"id":3262122,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-02-19T20:37:01.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":12598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":12598,"derivative":{"underlying":"Common Stock","underlying_shares":12598},"source":{"system":"sec-edgar","filing":"0000899243-20-005179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320005179/doc4.xml","form_type":"4"}},{"id":3262121,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T20:37:01.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":39022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2020, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":39022,"derivative":{"exercise_price":70.4,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":39022},"source":{"system":"sec-edgar","filing":"0000899243-20-005179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320005179/doc4.xml","form_type":"4"}},{"id":3294606,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-02-03T20:55:38.000Z","date":"2020-02-01","kind":"exercise","acquired":false,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":24375,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0000899243-20-002644","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320002644/doc4.xml","form_type":"4"}},{"id":3294605,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-03T20:55:38.000Z","date":"2020-02-01","kind":"sale","acquired":false,"shares":2899,"price":68.04,"value":197247.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Issuer's Common Stock sold to cover the Reporting Person's withholding taxes in connection with the vesting of 8,125 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":5226,"source":{"system":"sec-edgar","filing":"0000899243-20-002644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320002644/doc4.xml","form_type":"4"}},{"id":3294604,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-03T20:55:38.000Z","date":"2020-02-01","kind":"exercise","acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":8125,"source":{"system":"sec-edgar","filing":"0000899243-20-002644","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320002644/doc4.xml","form_type":"4"}},{"id":3673613,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-02-05T17:27:23.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The units shall vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The units shall vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The units shall vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":32500,"derivative":{"underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0000899243-19-002654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319002654/doc4.xml","form_type":"4"}},{"id":3673612,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-05T17:27:23.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":69500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable as to 25% of the option on February 1, 2020 and in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":69500,"derivative":{"exercise_price":40.99,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":69500},"source":{"system":"sec-edgar","filing":"0000899243-19-002654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319002654/doc4.xml","form_type":"4"}},{"id":4105202,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":37278,"kind":"person","name":"Fairey William","position":1,"cik":"0001727275","reported_name":"Fairey William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy","published_at":"2018-01-05T19:45:16.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":575000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2018.  25% of the total number of shares of common stock subject to the option will vest on January 3, 2019, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":575000,"derivative":{"exercise_price":6.19,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001209191-18-002575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340652/000120919118002575/doc4.xml","form_type":"4"}}]}